HIGHLIGHTS
- who: Posted Date April and colleagues from the University have published the research work: PolyI:C Suppresses TGF-β1-Induced Akt Phosphorylation and Reduces the Motility of A549 Lung Carcinoma Cells, in the Journal: (JOURNAL)
SUMMARY
Polyinosinic-polycytidylic acid (polyI:C), a synthetic agonist for toll-like receptor (TLR) 3, has been successfully used to treat some cancer patients as a vaccine adjuvant, but its direct action on the proliferation or migration of cancer cells, such as lung cancer cells, undergoing EMT remains unknown. Methods and results: By an in_vitro cell proliferation assay . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.